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Abstract
Serostatus disclosure is an important component of secondary HIV prevention with potential benefits for both
the individual by experiencing increased social support and society by reducing HIV transmission risk behav-
iors. This cross-sectional study assessed disclosure patterns to sex partners, family members, and friends by
sociodemographic and HIV-related factors among an urban, Midwestern U.S. HIV clinic population (n= 809); a
majority of whom were African American and male with a mean age of 41 years. Almost three quarters (n = 596)
of the sample was currently receiving HIV therapy, with 68% (n= 404) successfully suppressing their HIV viral
loads. Among sexually activity individuals, 97% reported disclosing their serostatus to sex partners. This high
rate of disclosure to sex partners suggests that social desirability may play a role in this self-reported measure.
Approximately half of the sample (n = 359) disclosed to at least one family member and 60% (n= 474) disclosed to
at least one friend. Disclosing to family members occurred more often among participants who were unem-
ployed and endorsed depressive disorder symptoms ( p < 0.05 for all). Disclosing to friends occurred more
frequently among women, Caucasians and those who completed higher levels of education ( p < 0.001 for all).
HIV disclosure and disease severity were unassociated. Given the chronic nature of HIV care, additional re-
search is needed to develop interventions to facilitate timely disclosure of HIV serostatus.
Introduction
The Centers for Disease Control and Prevention(CDC) estimates that 1.2 million individuals are living
with HIV in the United States, with 1 in 5 unaware of their
diagnosis.1 Despite recommendations for routine HIV testing
and aggressive prevention strategies, incident cases of HIV
infections remain stable at 56,000 annually. One of the re-
commended strategies for secondary prevention is the dis-
closure of HIV serostatus to potential sex partners. HIV
serostatus disclosure has been associated with the reduction
in HIV transmission,2–4 improved engagement in medical
care, adherence to medication, and reduction in levels of
psychological distress.5,6 Additionally, disclosure provides
individuals with opportunities for social support.7–11 From
a public health perspective, disclosure may motivate
sexual partners to seek testing and reduce HIV transmission
behaviors.12
Timing of HIV serostatus disclosure and to whom that
disclosure has occurred have previously been examined.Most
often, those who have reported non-disclosure attribute this
to fear of stigma, shame, and rejection.4,13 Individuals with
HIV infection are more likely to report serostatus disclosure
when engaged in a sustained, long-term sexual relationship
compared to brief or casual sexual relationships.2,14,15 While
disclosure to family and friends does not directly reduce the
risk of HIV transmission, individuals with HIV may experi-
ence significant benefit by expanding their potential support
network. Similar fears of stigma and rejection have been re-
ported regarding disclosure of HIV serostatus to family
members and friends.16 Older adults were less likely to dis-
close their serostatus to partners, relatives, and friends.17 In-
dividuals with advanced HIV disease or AIDS were more
likely to disclose their status than persons with asymptomatic
HIV disease.15,18 HIV serostatus disclosure to familymembers
has commonly occurred in later stages of illness,19,20
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suggesting that parental disclosure may be related to
heightened need for parents as caregivers.15,16,21
Since much of the research regarding HIV disclosure status
comes from the era before combination antiretroviral therapy
(cART), additional research needs to examine the process of
disclosure patterns among populations with HIV. The impact
of cART on the course of HIV disease is profound and has
altered the expectations for someone diagnosed with HIV.22
Correspondingly, issues surrounding HIV disclosure are
changing as HIV testing becomes de-stigmatized as a part of
routine medical care. Furthermore, as individuals with HIV
are expected to live longer, a greater number of opportunities
for disclosure may arise.1,22 The current study examines the
patterns of HIV serostatus disclosure to sex partners, family,
and friends among a sample of individuals with HIV engaged
in care during the cART era. The study was conducted in an
effort to augment research conducted earlier in the epidemic.
Given the transformation of HIV from a rapidly fatal illness to
a chronic manageable disease, a better understanding of the
dynamics of disclosure patterns remains an urgent need.
Methods
This cross-sectional study assessed the associations be-
tween disclosure to sex partners, family, and friends and so-
ciodemographic and HIV-related factors among an HIV clinic
population. As part of standard-of-care, all patients who at-
tended the Washington University HIV Clinic (WU HIV
Clinic) in St. Louis, Missouri, between June and December
2008 completed a behavioral assessment during routine clinic
visits. These assessments were conducted by trained inter-
viewers while individuals were waiting to be seen by their
health care providers. This study was approved by Wa-
shington University School of Medicine Human Research
Protection Office.
The assessments included measures of demographic char-
acteristics (gender, race/ethnicity, employment, education,
and annual income) and depressive symptomatology as
measured by the Patient Health Questionnaire (PHQ-9).23 The
PHQ-9 is used to calculate severity and symptom counts that
signify major depressive disorder (MDD) and other depres-
sive disorders (ODD). In these analyses we dichotomized the
PHQ-9 results to no or mild symptoms and MDD/ODD.
Disclosure patterns for sex partners, family, and friends were
analyzed separately. Specific questions about HIV serostatus
disclosure to casual and primary sex partners were evaluated
only among participants who reported sexual activity in the
previous 3 months.
Current CD4 cell count, plasma HIV RNA viral load, use,
and types of prescribed antiretroviral therapies were collected
at time of the visit. cART was defined as the use of at least
three drugs from two different antiretroviral drug classes or
the use of more than three nucleoside reverse transcriptase
inhibitors (NRTI).
Statistical analyses
Bivariate analyses (Pearson’s v2) were used to assess dif-
ferences in HIV serostatus disclosure to sex partners, family,
or friends by sociodemographic factors and HIV-related
measures (HIV RNA viral load and CD4 cell counts). Ana-
lyses related to virologic suppression (< 400 copies per milli-
liter) were conducted only with individuals who were on
cART. HIV viral loads were dichotomized (< 400 copies per
milliliter and > 400 copies per milliliter). Education levels
were dichotomized by less than or equal to high school
graduate/GED or higher than a high school degree.
Employment status was dichotomized into unemployed
(including receiving disability benefits) and employed (part
or full time). Annual income was dichotomized into less than
or equal to and more than $10,000. Depression severity was
dichotomized to those who expressed symptoms of major or
other depressive disorders (MDD/ODD) within the past 2
weeks and those who did not. Stepwise logistic regression
analyses were conducted to assess independent associations
with disclosure; univariate variables were included with
p < 0.1. Additional analyses were conducted among recently
sexually active participants (within 3 months) to identify so-
ciodemographic differences between individuals who have
had reported seronegative and seropositive partners. All tests
were two-tailed and p < 0.05 was considered significant. Data
analyses were performed using SPSS software (version 17.0,
SPSS Inc., Chicago, IL).
Results
A total of 809 individuals completed the interview with a
mean age of 42 years. The majority were male (n = 544; 67%)
andAfricanAmerican (n = 530; 71%). Almost three-quarters of
the sample was currently receiving cART (n = 596; 74%), with
68% (n= 405) achieving virologic suppression ( < 400 copies
per milliliter). The median length of time individuals had re-
ceived their current cART regimen was 1.0 year (interquartile
range [IQR]: 0, 2.4). See Table 1 for further description of the
study sample.
Among the individuals reporting sexual activity in the
previous 3 months (n = 344), 97% reported disclosing their
HIV serostatus to all sex partners (primary and causal).






African American/other 576 71.2
Caucasian 230 28.4
Unemployed 423 52.3
Annual income £ $10,000 425 52.5
£High school diploma/GED 439 54.3
MDD/ODD symptoms 289 35.7
Sex in last 3 months 344 42.5
Condom used at last sex 281 81.9
Receiving cART (n= 596) 596 73.7
Viral load < 50 copies/mL 336 56.4
>50 < 400 copies/mL 67 11.2
>400 copies/mL 192 32.2
CD4 cell count
0–199 cells/mm3 153 18.9
200–349 cells/mm3 152 18.8
350–499 cells/mm3 173 21.4
500+ cells/mm3 327 40.4
SD, standard deviation; cART, combination antiretroviral therapy.
aMean age – SD, 41.6– 11.0.
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Approximately half of the sample (n = 359) endorsed disclos-
ing to at least one family member (parents, grandparents,
siblings, aunts/uncles, cousins). Almost 60% reported dis-
closing their serostatus to at least one friend (n = 479). A small
proportion of the sample (n = 50; 6%) reported that no one
knew of their HIV status.
There were no significant factors associatedwith disclosure
to sex partners. The majority of participants who reported
having casual sex partners endorsed disclosing their HIV
status (n = 46; 75%). The majority (89%) reported using a
condom during their last sex event. Of those who reported
receptive or insertive vaginal sex, 79% and 72% reported al-
ways using condoms, respectively; among those who re-
ported receptive or insertive anal sex, 91% and 96%
participants, respectively, endorsed always using condoms.
Of the individuals who reported being sexually active in the
last 3 months (n = 344), 23 (7%) did not have a primary sex
partner and 14 (4%) did not know their sex partner’s HIV
status. Subanalyses were conducted to assess socio-
demographic differences among individuals who had and
knew their primary sex partner’s HIV status (n = 313). Of these
individuals, the majority had HIV-negative sex partners
(n = 180; 58%). African Americans more often reported pri-
mary sex partners that were HIV-positive (44% versus 29%;
p < 0.05) compared to Caucasian participants. Additionally,
individuals with an annual income less than or equal to
$10,000 more often reported having HIV-positive partners
(46% versus 32%; p < 0.05) than those with higher incomes.
These relationships are depicted in Table 2.
As noted above, a majority of persons had not disclosed
their serostatus to a family member. Disclosing to family
members occurred least often among individuals who were
older than 45 years of age compared to their younger coun-
terparts, 18–24 and 25–44 years (37% versus 49% and 50%;
p< 0.05). Individuals whowere unemployedwere more likely
to disclose their status than those who were employed (50%
versus 37%; p < 0.001) and similarly, individuals who re-
ported £ $10,000 annual income than those who reported
more (48% versus 40%; p < 0.05). Individuals who reported
significant depressive symptoms were more likely to disclose
their status to family members than those who were not de-
pressed (54% versus 38%; p< 0.001). There were no significant
associations between disclosure patterns to family members
and viral loads or CD4 cell counts. When controlling for
gender, age, education, and income, unemployed individuals
were 1.45 times more likely and individuals who expressed
depressive symptoms were 1.67 times more likely to disclose
to family members (Table 3).
Disclosing to friends occurred more often among men than
women (64% versus 48%; p< 0.001). Caucasians were more
likely to disclose than African Americans (71% versus 54%;
p< 0.001). Individuals with greater education were more likely
to disclose their status to friends (67% versus 51%; p< 0.001).
Individuals with income greater than $10,000 reported were
more likely to disclose (64% versus 54%; p< 0.05). When con-
trolling for income, women were 1.62 more likely to disclose,
Caucasians were 1.96 more likely, and individuals who com-
pleted greater educationwere 1.67 timesmore likely to disclose
their HIV status to their friends. There were no significant as-
sociations between disclosure to friends and HIV stage (as
measured by viral loads andCD4 cell counts). Table 4 describes
the associations between factors of disclosing to friends.Half of
the participants disclosed to both their family members and
friends (n= 280); while 10% disclosed only to their family
members and 24% only to their friends. Individuals who ex-
pressed depression symptoms were more likely to disclose to
both family members and friends (58% versus 46%; p= 0.006).
Discussion
The current study sought to examine HIV serostatus dis-
closure patterns to sexual partners, family members, and
friends in the era of cART among individuals with HIV who
are engaged in care. As individuals are living longer with HIV
and with less morbidity, few examinations of serostatus dis-
closure patterns have been conducted.13,16,24,25 We found
overall high rates of HIV disclosure to sex partners, family
members, and friends, which varied by sociodemographic
factors and depressive symptoms. This study found different
factors are significantly associated in disclosing HIV status to
family members and friends.
Nearly all individuals reported disclosure to sex partners.
This finding raises issues of questionable validity. Although
legislation has been implemented at the state level in the
United States (including Missouri where this study was con-
ducted) to compel individuals with HIV/AIDS to disclose
their status prior to engaging in sexual activity, previous
studies have reported lower rates of disclosure to sex part-
ners.26,27 Case managers are required to review these man-
dates annually with their clients.28 Fear of this enforcement is
likely to influence the social desirability regarding discussions
of patterns of disclosure of HIV serostatus to sex partners. Our
study population is highly disenfranchised as they live in
Table 2. Comparisons of Individuals with







n % n % p Value
Gender
Male 102 59.6 69 40.4 0.491
Female 77 63.6 44 36.4
Age 0.400
18–24 years 14 50.0 14 50.0
25–44 years 111 61.7 69 38.3
‡ 45 years 54 64.3 30 35.7
Race n % n %
African American/other 107 56.3 83 43.7 0.017
Caucasian 72 70.6 30 29.4
Employment status
Unemployed 90 58.8 63 41.2 0.321
Employed 89 64.5 49 35.5
Income
£ $10,000 79 54.5 66 45.5 0.020




85 59.4 58 40.6 0.522
>High school
diploma
94 63.1 55 36.9
All percentages shown are row percentages.
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impoverished communities and experience stigma related to
their sexual orientation (in cases of MSM) and HIV infection.
Thus, being asked questions about disclosure patterns within
the context of a clinic visit and knowing the mandates is likely
to increase discomfort in responding. Additionally, these
structural interventions may also serve as barriers to actual
disclosure to sex partners for fear of prosecution, violence,
and stigma.29 Other research has found that part of the pro-
cess for individuals with HIV to feel comfortable and confi-
dent to disclose their status to sexual partners, they need to
have psychologically processed their infection, how their
identity may have changed, and how this infection now in-
fluences their responsibility in sexual relationships; these
findings may be useful in development of interventions that
may be developed to address disclosure patterns among
identified individuals in need.13
While there was no variation in reported disclosure to sex
partners, this study found that individuals disclosed their
HIV status to family members more often when they ex-
pressed depressive symptoms and were unemployed. These
findings suggest that the independence of employment,
which likely protects individuals from other distress symp-
toms,30 may not promote disclosure to family members.
Unemployed individuals may require greater assistance
from family members for basic needs. Relating the conse-
quences and challenges of living with HIV may be necessary
to receive familial support in these situations. Individuals
who report more symptoms of depression may also be ex-
pressing more symptoms of or challenges with managing
their HIV,31–33 or perhaps express their need for psycho-
logical support due to their distress, as well as the disease.
Interestingly, the only significant difference among indi-
viduals that disclosed to family members and friends was
endorsing severe depressive symptoms. Requesting assis-
tance or support likely serves as a benefit for enhanced HIV
management.
Disclosure to friends occurred more often among Cauca-
sians, men, individuals who expressed depressive symptoms,
and those who attained higher levels of education. These
findings suggest how HIV has become less stigmatized in
some sub-populations in the United States, yet not in others.
More common disclosure to friends among Caucasian
men, specifically MSM, is not surprising given the well-
documented epidemiology of the early HIV epidemic. Again,
individuals who express depressive symptoms are disclosing
more often to friends. These depression-related findings
provide an intervention opportunity, as family members and
friends may provide needed support to the continued
Table 3. Disclosure Patterns to Family Members (n = 809)
Did not disclose Disclosed




of less likely to disclose
Gender
Male 314 57.7 230 42.3 0.097 1.30 (1.04, 1.74)
Female 136 51.3 129 48.7 Ref
Age
18–24 years 29 50.9 28 49.1 0.002
25–44 years 212 50.4 209 49.6
‡ 45 years 209 63.1 122 36.9
Race
African American/other 323 56.1 253 43.9 0.754 Ref
Caucasian 126 54.8 104 45.2 1.05 (1.29, 1.43)
Employment status
Unemployed 236 50.5 231 49.5 0.001 Ref Ref
Employed 213 62.6 127 37.4 1.64 (1.23, 2.18) 1.45 (1.08, 1.96)
Education
£High school diploma 218 52.7 196 47.3 0.089 Ref
>High school diploma 232 58.7 163 41.3 1.28 (1.03, 1.69)
Income (n = 794)
£ $10,000 219 51.5 206 48.5 0.015 Ref
> $10,000 222 60.2 147 39.8 1.42 (1.07, 1.88)
Depressive symptoms
Mild-no symptoms 281 61.9 173 38.1 0.001 1.90 (1.43, 2.54) 1.67 (1.24, 2.25)
MDD/ODD symptoms 151 46.0 177 54.0 Ref Ref
Current receipt of cART 331 55.5 265 44.5 1.000 1.01 (1.35, 1.39)
Viral load > 400 copies/mL (n = 596) 107 55.4 86 44.6 0.974 1.01 (1.40, 1.42)
CD4 cell count (n = 805)
0–199 cells/mm3 81 52.9 72 47.1 0.138
200–349 cells/mm3 93 61.2 59 38.8
350–499 cells/mm3 104 60.1 69 39.9
500 + cells/mm3 170 52.0 157 48.0
Associations indicate less likely to disclose to family members.
MDD, major depressive disorder; ODD, other depressive disorders.
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management of HIV. Having attained higher levels of edu-
cation likely alleviates some of the stigma surrounding HIV
infection and the risks of transmission. Intuitively, friends are
likely to provide social support, and previous research has
shown that friends are the most common recipients of HIV
disclosure.18 While it was not associated with HIV manage-
ment, the association of combined disclosure to friends and
family members suggests the existence of a larger support
network. These findings also support a better understanding
for needed interventions for the types of individuals who are
not disclosing their serostatus to family members and friends.
In the era of cART, perhaps the patterns of disclosure have
changed. Specifically, previous studies have indicated that
disclosure levels to friends are much lower than we have re-
ported here.15 It is likely that previous research was con-
ducted in the pre-cART era, where there seemed to be more
stigma associated with HIV diagnosis due to limited available
treatments. Additionally, HIV infection may have been in-
troduced at a much earlier age for many people in schools and
through media, although these messages are not recently
prevalent. The differential patterns of HIV status disclosure to
friends suggest a complex set of influences that has changed
over time and requires further investigation.
Our data suggest that serostatus disclosure continues to be
difficult for some sub-populations, likely attributable to many
factors including stigma and fear. Yet, overall we identified
high rates of disclosure. The finding that AfricanAmericans are
less likely to disclose to friends, highlights other research sug-
gesting that homophobia is more pernicious in African Amer-
ican communities, specifically men, older individuals, and
those living in rural areas.34 Moreover, overall HIV-related
stigma has also been prevalent in African American commu-
nities, which may also play an integral role in disclosing HIV
status.35 HIV-related stigma, fear of alienation and ostracism,
although not examined in this study, still serve as a barrier to
prevention efforts and likely impact non-disclosure rates par-
ticularly in our study amongAfricanAmericans, thosewho are
less educated, have lower income, and are younger.
Limitations
This was a cross-sectional study that was conducted from
one clinic population. The validity and reliability of ques-
tions related to disclosure patterns to sex partners, family
members, and friends has not been widely studied. We ex-
pect that we had questionable validity in the responses of
disclosure to sex partners, due to social desirability. It is
unclear whether those patterns are expected when surveying
patients about their disclosure to family members and
friends. While our findings suggest some variation of what
Table 4. Disclosure Patterns to Friends (n = 809)
Did not disclose Disclosed






of less likely to disclose
Gender
Male 198 36.4 346 63.6 Ref Ref
Female 137 51.7 128 48.3 2.86 (1.39, 2.52) 1.62 (1.19, 2.20)
Age 0.184
18–24 years 18 31.6 39 68.4
25–44 years 184 43.7 237 56.3
> 45 years 133 40.2 198 59.8
Race 0.001
African American/other 267 46.4 309 53.6 2.15 (1.55, 2.99) 1.96 (1.39, 2.776)
Caucasian 66 28.7 164 71.3 Ref Ref
Employment status 0.172
Unemployed 204 43.7 263 56.3 1.25 (1.06, 1.67)
Employed 130 38.2 210 61.8 Ref
Education 0.001
£High school diploma/GED 204 49.3 210 50.7 1.96 (1.47, 2.60) 1.67 (1.20, 2.18)
>High school diploma 131 33.2 264 66.8 Ref Ref
Income 0.007
£ $10,000 194 45.6 231 54.4 1.49 (1.12, 1.98)
> $10,000 133 36.0 236 64.0 Ref
Depressive symptoms
Mild-no symptoms 196 43.2 258 56.8 0.239 Ref
MDD/ODD Symptoms 127 38.7 258 61.3 1.20 (1.11, 1.61)
Receipt of cART 250 74.6 346 72.9 0.627 0.360 (0.137, 0.198)
Viral load > 400 copies/mL (n = 596) 86 44.6 107 55.4 0.377 0.833 (0.393, 0.972)
CD4 cell count
0–199 cells/mm3 66 43.1 87 56.9 0.230
200–349 cells/mm3 65 42.8 87 57.2
350–499 cells/mm3 81 46.8 92 53.2
500+ cells/mm3 123 37.6 204 62.4
MDD, major depressive disorders; ODD, other depressive disorders.
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has been known regarding disclosure, this study increases
understanding of the patterns that occur today in the era of
successful HIV therapy.
This study provides insight to family and friend HIV dis-
closure patterns that have not been discussed in the context of
recent medical advancements. Furthermore, disclosure of
serostatus to sex partners is complicated not only by fear of
rejection and stigma but also by fear of prosecution for re-
porting nondisclosure. The recently announced National
HIV/AIDS Strategy for the United States highlights efforts to
increase awareness of HIV today by focusing primarily on
increasing HIV testing, and secondary prevention efforts re-
main critical to success as well.36 Unfortunately, despite ad-
vances in medical care, stigma and fear of HIV persist as is
suggested in incomplete HIV disclosure to family members
and friends. The high rates of HIV serostatus disclosure in our
study illustrate that many individuals with HIV have dis-
closed their status with the potential to improve social sup-
port through disclosure. These findings suggest that we can
identify patterns of disclosure based on sociodemographic
and HIV-related characteristics, which may help providers
support their patients and clients in developing appropriate
support networks and secondary prevention interventions.
Without the support needed in managing HIV, self-care be-
haviors are likely to be ignored, and thus poorly impacting
HIV-related health outcomes and increasing HIV transmis-
sion risk behaviors. Additionally, secondary prevention ef-
forts to address serostatus disclosure both for sex partners and
overall social networks in order to provide avenues for sup-
port as individuals with HIV managing HIV infection and its
comorbidities is complicated. Serostatus disclosure is an in-
tegral component in the secondary prevention effort to reduce
incident HIV infections.
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